| Line 461: |
Line 461: |
| | | | |
| | ==Miscellaneous agents== | | ==Miscellaneous agents== |
| − | Allopurinol
| |
| − | Decreases production of uric acid
| |
| − | Dose not established
| |
| | | | |
| − | Aminophylline
| + | ===Allopurinol=== |
| − | Bronchodilator
| + | *Decreases production of uric acid |
| − | 2-4 mg/kg IM
| + | *Dose not established |
| | | | |
| − | Atropine
| + | ===Aminophylline=== |
| − | OP toxicity
| + | *Bronchodilator |
| − | 0.1-0.2 mg/kg IM
| + | *2-4 mg/kg IM |
| | | | |
| − | Cimetidine
| + | ===Atropine=== |
| − | Gastric and duodenal ulcerations
| + | *OP toxicity |
| − | Oesophageal and gastric reflux
| + | *0.1-0.2 mg/kg IM |
| − | 4 mg/kg PO, IM q8-12h
| |
| | | | |
| − | Flunixin meglumine
| + | ===Cimetidine=== |
| − | Non-steroidal anti-inflammatory
| + | *Gastric and duodenal ulcerations |
| − | 0.1-0.5 mg/kg IM, SC q12-24h 1-2d
| + | *Oesophageal and gastric reflux |
| | + | *4 mg/kg PO, IM q8-12h |
| | | | |
| − | Furosemide | + | ===Flunixin meglumine=== |
| − | Diuretic | + | *Non-steroidal anti-inflammatory |
| − | 5 mg/kg PO, IM, IV q12-24h | + | *0.1-0.5 mg/kg IM, SC q12-24h 1-2d |
| | + | |
| | + | ===Furosemide=== |
| | + | *Diuretic |
| | + | *5 mg/kg PO, IM, IV q12-24h |